Skip to results
Modify your search
NARROW
1-20 of 38
Authors: Johan Askling
Journal Article
Impact of incident rheumatoid arthritis on earnings: a nationwide sibling comparison study Open Access
Rheumatology, keae535, https://doi.org/10.1093/rheumatology/keae535
Published: 16 October 2024
Journal Article
Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis Open Access
Rheumatology, Volume 63, Issue 5, May 2024, Pages 1221–1229, https://doi.org/10.1093/rheumatology/kead301
Published: 16 June 2023
Journal Article
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries Open Access
Rheumatology, Volume 63, Issue 3, March 2024, Pages 751–764, https://doi.org/10.1093/rheumatology/kead284
Published: 14 June 2023
Journal Article
Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model application Open Access
Rheumatology, Volume 62, Issue 10, October 2023, Pages 3391–3399, https://doi.org/10.1093/rheumatology/kead083
Published: 23 February 2023
Journal Article
Comment on: The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis: reply Free
Rheumatology, Volume 62, Issue 6, June 2023, Page e204, https://doi.org/10.1093/rheumatology/keac649
Published: 17 November 2022
Journal Article
The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis Open Access
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2106–2112, https://doi.org/10.1093/rheumatology/keac601
Published: 18 October 2022
Journal Article
Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries Open Access
Rheumatology, Volume 62, Issue 2, February 2023, Pages 647–658, https://doi.org/10.1093/rheumatology/keac358
Published: 20 June 2022
Journal Article
Correction to: Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration Open Access
Rheumatology, Volume 61, Issue 12, December 2022, Page 4998, https://doi.org/10.1093/rheumatology/keac151
Published: 25 March 2022
Journal Article
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis Free
Rheumatology, Volume 61, Issue 12, December 2022, Pages 4741–4751, https://doi.org/10.1093/rheumatology/keac174
Published: 22 March 2022
Journal Article
Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration Open Access
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4286–4296, https://doi.org/10.1093/rheumatology/keac081
Published: 09 February 2022
Journal Article
Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data Open Access
Rheumatology, Volume 61, Issue 10, October 2022, Pages 3952–3962, https://doi.org/10.1093/rheumatology/keac068
Published: 03 February 2022
Journal Article
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response Free
Rheumatology, Volume 61, Issue 9, September 2022, Pages 3799–3807, https://doi.org/10.1093/rheumatology/keab945
Published: 23 December 2021
Journal Article
The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries Free
Rheumatology, Volume 61, Issue 9, September 2022, Pages 3647–3656, https://doi.org/10.1093/rheumatology/keab946
Published: 23 December 2021
Journal Article
Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden Open Access
Rheumatology, Volume 61, Issue 9, September 2022, Pages 3596–3605, https://doi.org/10.1093/rheumatology/keab933
Published: 17 December 2021
Journal Article
Comment on: Incidence of extra-articular manifestations in AS, PsA and undifferentiated SpA: results from a national register-based cohort study. Reply Free
Rheumatology, Volume 61, Issue 1, January 2022, Page e31, https://doi.org/10.1093/rheumatology/keab745
Published: 14 October 2021
Journal Article
Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice Open Access
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1810–1818, https://doi.org/10.1093/rheumatology/keab570
Published: 29 July 2021
Journal Article
Juvenile idiopathic arthritis, marriage and parenthood: a nationwide matched cohort study Open Access
Rheumatology, Volume 61, Issue 3, March 2022, Pages 1228–1232, https://doi.org/10.1093/rheumatology/keab536
Published: 10 July 2021
Journal Article
Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors – a Nordic cohort study Free
Rheumatology, Volume 60, Issue 8, August 2021, Pages 3656–3668, https://doi.org/10.1093/rheumatology/keaa828
Published: 05 January 2021
Journal Article
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis Free
Rheumatology, Volume 60, Issue 8, August 2021, Pages 3635–3645, https://doi.org/10.1093/rheumatology/keaa825
Published: 26 December 2020
Journal Article
Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control study Free
Rheumatology, Volume 60, Issue 8, August 2021, Pages 3760–3769, https://doi.org/10.1093/rheumatology/keaa856
Published: 17 December 2020
